5 Brevetto
 Distribuzione geografica
Continente #
EU - Europa 11.545
NA - Nord America 9.435
AS - Asia 4.991
SA - Sud America 242
Continente sconosciuto - Info sul continente non disponibili 162
AF - Africa 59
OC - Oceania 9
Totale 26.443
Nazione #
US - Stati Uniti d'America 9.329
NL - Olanda 3.816
GB - Regno Unito 2.357
CN - Cina 2.150
IT - Italia 1.559
SG - Singapore 1.134
UA - Ucraina 887
SE - Svezia 835
JP - Giappone 673
DE - Germania 499
TR - Turchia 492
FR - Francia 370
RU - Federazione Russa 312
FI - Finlandia 309
VN - Vietnam 223
IE - Irlanda 166
BR - Brasile 165
AT - Austria 130
BE - Belgio 100
PL - Polonia 79
IN - India 74
CA - Canada 68
EU - Europa 61
KR - Corea 56
BD - Bangladesh 43
ES - Italia 32
AR - Argentina 29
HK - Hong Kong 29
RO - Romania 22
MX - Messico 19
ZA - Sudafrica 14
CO - Colombia 13
IQ - Iraq 13
KE - Kenya 13
VE - Venezuela 12
EC - Ecuador 11
ID - Indonesia 11
LT - Lituania 11
MA - Marocco 10
PK - Pakistan 10
PT - Portogallo 10
CH - Svizzera 9
SA - Arabia Saudita 9
JO - Giordania 8
PH - Filippine 8
TG - Togo 8
AU - Australia 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
MY - Malesia 6
EE - Estonia 5
IR - Iran 5
AL - Albania 4
BG - Bulgaria 4
DK - Danimarca 4
IL - Israele 4
KG - Kirghizistan 4
KZ - Kazakistan 4
AZ - Azerbaigian 3
CL - Cile 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
HR - Croazia 3
JM - Giamaica 3
LV - Lettonia 3
NP - Nepal 3
PE - Perù 3
PY - Paraguay 3
TN - Tunisia 3
UZ - Uzbekistan 3
BO - Bolivia 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
LU - Lussemburgo 2
MD - Moldavia 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
ET - Etiopia 1
GD - Grenada 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
Totale 26.328
Città #
Amsterdam 3.793
Southend 2.184
Dallas 1.914
Chandler 823
Jacksonville 684
San Jose 668
Ann Arbor 650
Ashburn 619
Singapore 539
Nanjing 491
Houston 391
Woodbridge 366
Izmir 364
Urbino 333
Beijing 331
Boardman 185
Nanchang 174
Munich 165
Dublin 153
New York 148
Wilmington 148
Council Bluffs 146
Helsinki 140
Düsseldorf 136
Vienna 128
San Mateo 122
Dong Ket 106
Princeton 104
Lauterbourg 102
Los Angeles 102
Des Moines 100
Brussels 98
Orciano Di Pesaro 92
Kunming 90
Cambridge 83
Jiaxing 74
Shenyang 69
Tianjin 69
Fairfield 67
Santa Clara 67
Istanbul 66
Milan 66
Hebei 65
Changsha 62
Moscow 60
Velikiy Novgorod 57
Seongnam 52
Kraków 50
Shanghai 47
Ho Chi Minh City 41
Hangzhou 40
Rome 39
Buffalo 38
Bremen 36
Lanzhou 33
Frankfurt am Main 32
Paris 32
Seattle 32
Jinan 31
Tokyo 31
Toronto 31
Venice 29
Ancona 27
Hanoi 26
Wuppertal 26
San Francisco 24
Changchun 23
The Dalles 23
Turku 23
Warsaw 23
Hong Kong 22
Dearborn 21
Guangzhou 20
Montreal 20
Stockholm 20
Brooklyn 19
Atlanta 18
Civitanova Marche 18
West Jordan 18
Chicago 17
Phoenix 17
Bologna 16
Ningbo 16
Zhengzhou 16
Florence 15
London 15
Poplar 15
Denver 14
Nuremberg 14
Orem 14
Redwood City 14
Boston 13
Manchester 13
São Paulo 13
Chennai 12
Dormagen 12
Ascoli Piceno 11
Johannesburg 11
Macerata 11
Mexico City 11
Totale 18.649
Nome #
1,5-BENZODIAZEPINE-2,4-DIONE GASTRIN AND CHOLECYSTOKININ-B-RECEPTOR ANTAGONISTS 3.160
1,7-DIHYDROPYRROLO[3,4-e][1,4]DIAZEPIN-2(3H)-ONE DERIVATIVES, AND THEIR USE AS ANTICONVULSANT AND ANTIANXIETY AGENTS 3.157
Derivative of [(3-hydroxy-4-pyron-2-yl)-methyl]-amine and use thereof as anti-neoplastic drugs 362
Metodo di sintesi di derivati del glutatione [Method for the synthesis of glutathione derivatives] 346
Device and single-molecule analysis method by means of detection of the collisions of a target molecule on functionalized nanopores 329
DEVICE FOR EMULATING ENERGY SOURCES USED TO POWER EMBEDDED SYSTEMS/DEVICES 326
Pharmaceutical composition of [(3-​hydroxy-​4 -​pyron-​2-​yl) methyl] -​amine derivatives and DNA demethylating agents and their use as anti-​neoplastic drugs 297
Microfluidic-formulated leukosome compositions and fabrication methods therefor 291
METHOD FOR PRODUCING OPTICALLY ACTIVE 1,2-DIAMINE COMPOUND AND OPTICALLY ACTIVE NIOBIUM CATALYST 263
10-(1-HYDROXYMETHYL)-11-OXO-1-AZATRICYCLOUNDEC-2-ENE-2-CARBOXYLIC ACID ESTERS USEFUL AS ANTIBACTERIAL AND PROCESS FOR THEIR PREPARATION 259
Apparecchiatura per misurare la quantità di idrocarburi volatili presenti nell'aria 255
2,4,5-TRISUBSTITUTED OXAZOLES 251
Method of evaluating the response of ataxia telangiectasia patients to glucocorticoids treatment 250
Pharmaceutical composition or composition package containing a pyrimidine nucleoside analog and a purine nucleoside analog 249
SULODEXIDE FOR USE IN THE TREATMENT OF PATHOLOGIES WHEREIN METALLOPROTEINASES ARE INVOLVED 249
Corpo cavo di Sonda geotermica e Sonda geotermica 242
Modulation of Anxiety Through Blockade of Anandamide Hydrolysis 240
Drug delivery systems 239
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 239
"Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions" 237
Acyclovir prodrug and its use in pharmaceutical compositions 237
Method And Relative Test Structure For Measuring The Coupling Capacitance Between Two Interconnect Lines 234
TEICOPLANIN HYDRAZIDES AS ANTIBACTERIALS 230
Uso del Sulodexide per la riduzione delle metalloproteasi di matrice 230
5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht7 serotonin receptors, preparation, and therapeutic use.. 229
Processo per la preparazione di esteri degli acidi 2-aril-alcanoici 228
Attrezzo ginnico sportivo 227
3,6-DISUBSTITUTED TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES 224
Control system of acoustic echo cancellers for telephone terminals with handset or handsfree 224
5-fluorocitosina come agente antibatterico 223
Peripherally Restricted FAAH Inhibitors 220
Biomimetic proteolipid vesicle compositions and uses thereof 219
Production of triterpenic acids by in vitro culture of calluses deriving from the pulp of red sentinel apples 219
Delivery of Contrasting Agents for Magnetic Resonance Imaging 217
Procedimento perfezionato per la riduzione di composti organici mediante l'impiego di idruro di magnesio 216
Pharmaceutical composition for the parenteral administration of melatonin, and a process for its preparation 214
Filtro per l’equalizzazione e/o la Linearizzazione sistemi non lineari 212
A process for the preparation of monosialoganglioside by autolysis of cattle brain. 209
Apparecchiatura per misurare la quantità di idrocarburi volatili presenti nell’aria 209
Alchilammidi tricicliche: legandi selettivi dei recettori melatoninergici MT1 e MT2 207
Procedimento per la preparazione di monosialoganglioside 206
DEVICE FOR GENERATING MICRO- AND NANO-FLOW MOBILE PHASE GRADIENTS FOR HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY 206
“Tretamerous derivative of indole-3-carbinol with anticancer activity and method of synthesis of said derivative “ 205
Procedimento per ottenere una sostanza antiossidante da peci fenoliche. 200
Procedimento per la preparazione di biopolimeri 200
Nanoparticles for delivery of a pharmacologically active agent 198
Nutritional supplement, especially for dairy products, comprises leptin. 195
Procedimento per la produzione di esteri metilici di acidi grassi per reazione di trigliceridi di origine naturale con alcol metilico in presenza di resine 194
5-fluorocitosina come agente antibatterico 194
AMINOPYRROLE DERIVATIVES 190
Use of microparticles for antigen delivery 189
Oxidated derivatives of triazolylpurines useful as ligands of the adenosine A2A receptor and their use as medicaments 187
A process for obtaining chemically defined and reproducible polydeoxyribonucleotides. 186
DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2a RECEPTOR AND THEIR USE AS MEDICAMENTS. 186
DERIVATIVES OF [(3-HYDROXY-4-PYRON-2-YL)-METHYL]-AMINE AND USE THEREOF AS ANTI-NEOPLASTIC DRUGS 186
Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions” PCT/EP 92/01291 185
Derivati 2-Acilamminoalchilindolici come Antagonisti/Agonisti Parziali della Melatonina 180
Derivatives of triazoly-imidazopyridine useful as ligands of the adenosine A2a receptor ant their use as medicaments 179
PYRROLO[3,4-d]PYRIMIDINES 177
Preparation of glutathione derivatives as antiviral agents 177
ANTIINFLAMMATORY OXAZOLES 173
PYRROLO[3,4-d]PYRIMIDINES 173
“ ,Processo de producao de antioxidante alquilado, obtido a partir de fenois, cresois e preferencialmente do cardanol hidrogenado, 3-pentadecilfenol (3-PDP) aplicavel como aditivo em combustiveis e lubrificantes. “ 171
PROCEDIMENTO DI SELEZIONE AUTOMATICA DI FOTOGRAFIE DIGITALI DA UN ARCHIVIO PER LA CREAZIONE AUTOMATICA DI UNA SEQUENZA DI FOTO CHE RAPPRESENTA UNA STORIA EMOZIONALE DA STAMPARE E/O CONSERVARE 171
DERIVATI DI [(3-IDROSSI-4-PIRON-2-IL)METIL]-AMINA E LORO USO COME FARMACI ANTI-NEOPLASTICI 170
USE OF ISOLATED MATURE ADIPOCYTES IN REGENERATIVE MEDICINE FOR THE RECONSTRUCTION AND REPARATION OF TISSUES 169
Derivato tetramerico dell'indol-3-carbinolo ad attività anticancerogena e metodo di sintesi del derivato stesso 167
PREPARATION OF 3-UREIDO-2,4-DIOXOTETRAHYDRO-1,5-BENZODIAZEPINES AS CCK AND GASTRIN ANTAGONISTS 166
3,7-DIHYDROPYRROLO[3,4-e][1,4]DIAZEPIN-2(1H)-ONE DERIVATIVES 165
PREPARATION OF ANELLATED CARBAPENEMS AS ANTIBIOTICS 165
Procedimento di valutazione automatica della qualità di foto digitali 165
PREPARATION AND TESTING OF N15-ALKYL AND N15,N15-DIALKYL DERIVATIVES OF TEICOPLANIN COMPOUNDS AS BACTERICIDES 164
3-AMINO-4-CARBAMYLPYRROLE DERIVATIVES 164
PHARMACOLOGICALLY ACTIVE PYRROLODIAZEPINES 162
Procedimento per la produzione di derivati t-butilati del cardanolo e del 3-n-pentadecilfenolo 161
Derivati 1-Acilamminoalchilindolici come agonisti della melatonina. 161
Derivati fosforilati del cardanolo o del 3-n-pentadecilfenolo utili come additivi per lubrificanti e procedimento per la loro preparazione. 159
Nanosfere polimeriche e relativo utilizzo per veicolare oligonucleotidi. 159
PREPARATION OF 13-DE(ACETAMIDOGLUPYRANOSYL)-34-DEOXYTEICOPLANIN DERIVATIVES AS ANTIBACTERIALS 158
PYRROLODIAZEPINE DERIVATIVES 156
AMINOPYRROLE DERIVATIVES 156
PYRROLODIAZEPINES 156
PYRROLO[3,4-b]PYRIDINES 152
Preparation of heterocyclic compounds as fluorescent probes for detection in biological systems 151
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 148
Preparation of 2-trichloroacetoxy-3,4,5,6-tetrachlorobenzoic acid and compositions containing same for treating benign mammalian neoformations. 147
Methods, Compositions, and Other Compounds for Modulation of Monoacylglycerol Lipase Pain, and Stress-related Disorders 145
Nuovo procedimento per la raffinazione dell'olio derivato dai gusci delle noci di anacardio e prodotto ottenuto con tale procedimento. 145
MACCHINA PER ANALISI CHIMICA COMPRENDENTE LA COMBINAZIONE DELLA SPETTROMETRIA DI MASSA A IONIZZAZIONE ELETTRONICA CON LA CROMATOGRAFIA LIQUIDA 145
Procedimento per la produzione di antiossidanti solforati da derivati dell'olio del guscio della noce di anacardio. 144
PREPARATION OF DE(ACETYLGLUCOSAMINYL)DIDEHYDRODEOXYTEICOPLANIN DERIVATIVES AS ANTIBIOTICS 140
Manufacture of antioxidants for rubbers from phenolic pitch. 139
ANTIINFLAMMATORY 4,5-OXAZOLEDICARBOXAMIDES 139
Inhibitors of anandamide transport and their therapeutic use 138
Procedimento per la preparazione di derivati perfluorurati del cardanolo utili come intermedi organici, idrorepellenti, impregnanti, insetticidi, fitofarmaci e precursori di bisfenoli, resine fenoliche o resine fenoliche modificate. 135
Derivati del glutatione e loro utilizzi per il trattamento di malattie virali 134
Novel melatonin ligands having antidepressant activity as well as sleep inducine properties 133
PREPARATION OF 22-DECHLOROTEICOPLANIN AS ANTIBACTERIALS 128
Filter for the equalization and/or linearization of non-Linear systems 126
Preparation and anticancer activity of tetramerous deriv. of indole-3-carbinol. 126
Totale 25.615


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022835 0 0 0 244 29 8 34 59 88 44 13 316
2022/20232.093 253 177 137 225 152 482 8 173 266 45 123 52
2023/2024625 56 62 29 51 41 152 39 65 3 35 17 75
2024/20251.768 152 64 434 117 49 112 151 108 180 97 193 111
2025/20269.366 390 851 1.565 623 338 340 676 132 3.992 181 197 81
2026/2027576 107 104 290 75 0 0 0 0 0 0 0 0
Totale 26.443